Skip to main content

Table 3 Prevalence odds ratios and 95 % confidence intervals for metabolic syndromes according to urinary phthalate metabolites in men and women

From: The association between phthalates and metabolic syndrome: the National Health and Nutrition Examination Survey 2001–2010

 

Overall population

 

Men

 

Women

 
 

(n = 2719)

(n = 1388)

(n = 1331)

 

Model 1a

Model 2b

Model 1a

Model 2c

Model 1a

Model 2c

MEP

      

 Q1

Ref

Ref

Ref

Ref

Ref

Ref

 Q2

1.07 (0.82, 1.40)

1.16 (0.88, 1.54)

0.92 (0.63, 1.34)

0.98 (0.66, 1.45)

1.21 (0.84, 1.75)

1.46 (0.97, 2.19)

 Q3

0.94 (0.69, 1.27)

0.98 (0.71, 1.37)

0.97 (0.62, 1.53)

0.97 (0.58, 1.61)

0.86 (0.59, 1.27)

1.02 (0.66, 1.56)

 Q4

1.20 (0.91, 1.59)

1.18 (0.88, 1.59)

1.33 (0.90, 1.96)

1.35 (0.87, 2.11)

1.04 (0.71, 1.51)

1.11 (0.72, 1.72)

MBzP

 Q1

Ref

Ref

Ref

Ref

Ref

Ref

 Q2

1.33 (1.00, 1.75)

1.40 (1.04, 1.89)

1.25 (0.83, 1.87)

1.19 (0.75, 1.87)

1.34 (0.96, 1.88)

1.55 (1.07, 2.26)

 Q3

1.27 (0.92, 1.78)

1.37 (0.96, 1.96)

1.04 (0.68, 1.59)

1.01 (0.63, 1.63)

1.49 (0.95, 2.35)

1.71 (1.05, 2.80)

 Q4

1.27 (0.86, 1.86)

1.44 (0.98, 2.12)

1.03 (0.62, 1.70)

1.08 (0.65, 1.79)

1.46 (0.90, 2.36)

1.69 (0.97, 2.93)

MnBP

 Q1

Ref

Ref

Ref

Ref

Ref

Ref

 Q2

1.23 (0.92, 1.66)

1.21 (0.90, 1.63)

1.10 (0.73, 1.64)

1.06 (0.71, 1.58)

1.35 (0.95, 1.91)

1.31 (0.90, 1.89)

 Q3

0.97 (0.71, 1.33)

0.94 (0.67, 1.33)

0.66 (0.41, 1.07)

0.57 (0.34, 0.96)

1.37 (0.99, 1.90)

1.45 (0.98, 2.16)

 Q4

1.23 (0.88, 1.73)

1.22 (0.85, 1.75)

1.37 (0.87, 2.17)

1.43 (0.85, 2.40)

1.09 (0.69, 1.74)

1.03 (0.60, 1.77)

MCPP

 Q1

Ref

Ref

Ref

Ref

Ref

Ref

 Q2

1.09 (0.82, 1.45)

1.05 (0.77, 1.44)

1.09 (0.74, 1.61)

0.96 (0.62, 1.49)

1.04 (0.71, 1.52)

1.05 (0.71, 1.57)

 Q3

1.02 (0.72, 1.43)

0.94 (0.65, 1.34)

0.91 (0.60, 1.38)

0.75 (0.48, 1.18)

1.07 (0.68, 1.68)

0.97 (0.57, 1.66)

 Q4

1.25 (0.91, 1.72)

1.12 (0.80, 1.56)

1.30 (0.85, 2.01)

0.99 (0.63, 1.58)

1.11 (0.72, 1.70)

1.08 (0.68, 1.71)

MiBP

 Q1

Ref

Ref

Ref

Ref

Ref

Ref

 Q2

1.04 (0.78, 1.38)

1.07 (0.78, 1.47)

0.91 (0.64, 1.30)

0.94 (0.63, 1.38)

1.14 (0.73, 1.78)

1.13 (0.71, 1.81)

 Q3

0.88 (0.64, 1.20)

0.88 (0.61, 1.27)

0.72 (0.46, 1.12)

0.72 (0.43, 1.19)

1.03 (0.66, 1.61)

1.04 (0.64, 1.70)

 Q4

1.14 (0.86, 1.52)

1.28 (0.91, 1.80)

0.98 (0.69, 1.40)

1.05 (0.66, 1.65)

1.25 (0.74, 2.09)

1.40 (0.77, 2.55)

∑DEHP

 Q1

Ref

Ref

Ref

Ref

Ref

Ref

 Q2

1.62 (1.25, 2.11)

1.64 (1.24, 2.17)

1.69 (1.23, 2.34)

1.60 (1.11, 2.31)

1.52 (1.07, 2.17)

1.58 (1.09, 2.29)

 Q3

1.55 (1.16, 2.09)

1.64 (1.22, 2.22)

1.71 (1.17, 2.51)

1.69 (1.16, 2.46)

1.38 (0.86, 2.22)

1.43 (0.89, 2.29)

 Q4

1.59 (1.12, 2.25)

1.94 (1.35, 2.80)

1.87 (1.19, 2.94)

2.20 (1.32, 3.68)

1.27 (0.78, 2.06)

1.50 (0.89, 2.52)

  1. aAdjusted for urinary creatinine
  2. bAdjusted for urinary creatinine, age, sex, race/ethnicity, total caloric intake, education, physical activity, smoking, and poverty
  3. cAdjusted for the same variables in b except sex
Back to article page

Environmental Health

ISSN: 1476-069X